Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Pharmaconutrition‒Modern drug design for functional studies


Antonella Di Pizio and Maik Behrens of the Leibniz-Institute for Food Systems Biology at the Technical University of Munich, together with their cooperation partners, have developed highly effective activators for the bitter receptor TAS2R14 in a German-Israeli research project. The new substances are used to investigate the as yet unknown physiological functions of the receptor, for example, in the human immune system.

The team of scientists published their results in the journal Cellular and Molecular Life Sciences (Di Pizio et al., 2019; DOI: 10.1007/s00018-019-03194-2).

Bitter (taste) receptor with health effect?

Model of the bitter receptor TAS2R14 with activator (ligand) flufenamic acid

Dr. Antonella Di Pizio / Leibniz-LSB@TUM

Dr. Antonella Di Pizio, lead author

C. Schranner / Leibniz-LSB@TUM

It has only been known for approximately 15 years that humans detect bitterness with the aid of 25 different receptor variants. TAS2R14 is one of these. However, unlike most of the other bitter receptors, it detects a broad spectrum of bitter substances.

In addition to secondary plant substances, such as caffeine, its activators also include medications. However, the bitter receptor is not just relevant for taste perception.

Recent findings indicate that it provides other physiological functions that are important for our health. It is found on lung and testicle cells and plays a role in the innate immune response.

Old drug substance as the basis for modern drug design

In order to specifically investigate the manifold functions of TAS2R14 in different organs and tissues, among other things, highly effective (potent) activators of the receptor are necessary. Using a structure-based computer-aided modeling approach, the German-Israeli team of scientists has now succeeded for the first time in synthesizing three such highly potent substances.

The original substance for the drug design was the drug flufenamic acid. The well-known active ingredient is one of the non-steroidal anti-inflammatory drugs and is contained in muscle and joint salves. It has an anti-inflammatory and analgesic effect, in that it blocks enzymes that promote the release of prostaglandins.

"We chose this active ingredient as the basis for our investigations because it stimulates the receptor even in the most minute concentrations. This means that approximately eight millionths of a gram of the substance per liter are already sufficient for this purpose," explains bioinformatician and lead author, Antonella Di Pizio. The new derivatives are extremely potent activators, more effective than the known drug, and in the future they will be used as tools in functional studies.

A new research area "pharmaconutrition" with a systems biology approach

"Due to the many new findings, we no longer regard bitter substances exclusively as pure flavoring components, but also as medically effective nutritional components," says molecular biologist Maik Behrens.

"Likewise, today bitter receptors must no longer be viewed as just sensors that warn us of potentially toxic substances before swallowing." To research the correlations between bitter substances, bitter receptors and the human organism a new, far-reaching systems biology approach is required, the biologist continued. The Leibniz Institute is pursuing this approach by combining basic molecular research with the latest methods of bioinformatics and high-throughput technologies.

Background Information:

Not just good for smelling and tasting–Chemoreceptors offer approaches for the development of new drug therapies
Odor and taste receptors are found not only in the nose and mouth. Recent studies indicate that they perform other functions in the body, for example, in the immune system or the regulation of metabolism.

Therefore, they could serve as starting points for computer-assisted development of new therapeutics. A review article of the Leibniz-LSB@TUM now summarizes the current data situation on this topic.

Di Pizio A, Behrens M, Krautwurst D. (2019) International Journal of Molecular Sciences, DOI: 10.3390/ijms20061402. Beyond the flavor: the potential druggability of chemosensory GPCRs

Read also:
Reengineering the ligand sensitivity of the broadly tuned human bitter taste receptor TAS2R14. Nowak S, Di Pizio A, Levit A, Niv MY, Meyerhof W, Behrens M. Biochim Biophys Acta. 2018 Jul 12. pii: S0304-4165(18)30200-9.;

Probing the binding pocket of the broadly tuned human bitter taste receptor TAS2R14 by chemical modification of cognate
agonists. Karaman R, Nowak S, Di Pizio A, Kitaneh H, Abu-Jaish A, Meyerhof W, Niv MY, Behrens M. Chem Biol Drug Des. 2016 Jul; 88(1):66-75. doi: 10.1111/cbdd.12734.

The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14. Levit A, Nowak S, Peters M, Wiener A, Meyerhof W, Behrens M, Niv MY. FASEB J. 2014 Mar; 28(3):1181-97. doi: 10.1096/fj.13-242594.

Press Contact:
Dr. Gisela Olias
Press and Public Relations
phone: +49 816171 2980

The Leibniz-Institute for Food Systems Biology at the Technical University of Munich (Leibniz-LSB@TUM) has a unique research profile. Its researchers combine methods of basic biomolecular research with analytical methods of bioinformatics and analytical high-performance technologies. Their goal is to decode the complex ingredient profiles from raw materials to the final food products and to elucidate their function as biological active molecules on humans. Based on their studies, the scientists develop products, which are as healthy as they are tasty. These foods will help to provide a sustainable and sufficient stream of food for future generations. In addition, the new scientific findings will be used to develop personalized nutritional concepts that, for example, help people with food intolerance without compromising quality of life and endangering their health.

The Leibniz LSB@TUM is a member of the Leibniz Association, which connects 95 independent research institutions. Their orientation ranges from the natural sciences, engineering and environmental sciences through economics, spatial and social sciences to the humanities. Leibniz Institutes devote themselves to social, economic and ecological issues. They conduct knowledge-oriented and application-oriented research, also in the overlapping Leibniz research networks, are or maintain scientific infrastructures and offer research-based services. The Leibniz Association focuses on knowledge transfer, especially with the Leibniz Research Museums. It advises and informs politics, science, business and the public. Leibniz institutions maintain close cooperation with universities - among others, in the form of the Leibniz Science Campuses, industry and other partners in Germany and abroad. They are subject to a transparent and independent review process. Due to their national significance, the federal government and the federal states jointly fund the institutes of the Leibniz Association. The Leibniz Institutes employ around 20,000 people, including 10,000 scientists. The entire budget of all the institutes is more than 1.9 billion euros.

Wissenschaftliche Ansprechpartner:

Dr. habil. Maik Behrens
Section II, Work Group Taste Systems Reception & Biosignals
Leibniz-Institute for Food Systems Biology at the TU Munich (Leibniz-LSB@TUM)
phone: +49 816171 2987
Profile of Dr. habil. Maik Behrens:

Dr. Antonella Di Pizio
Section III, Work Group Computational Pharmacology
phone: +49 816171 2904
Profile of Dr. Antonella Di Pizio:


Di Pizio A, Waterloo LAW, Brox R, Löber S, Weikert D, Behrens M, Gmeiner P, Niv MY (2019) Cellular and Molecular Life Sciences, DOI: 10.1007/s00018-019-03194-2. Rational design of agonists for bitter taste receptor TAS2R14: from modeling to bench and back

Weitere Informationen:

Dr. Gisela Olias | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Going the distance: Brain cells for 3D vision discovered
28.06.2019 | Newcastle University

nachricht Artificial DNA can control release of active ingredients from drugs
28.06.2019 | Technische Universität München

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First results of the new Alphatrap experiment

Physicists at the Max Planck Institute for Nuclear Physics in Heidelberg report the first result of the new Alphatrap experiment. They measured the bound-electron g-factor of highly charged (boron-like) argon ions with unprecedented precision of 9 digits. In comparison with a new highly accurate quantum electrodynamic calculation they found an excellent agreement on a level of 7 digits. This paves the way for sensitive tests of QED in strong fields like precision measurements of the fine structure constant α as well as the detection of possible signatures of new physics. [Physical Review Letters, 27 June 2019]

Quantum electrodynamics (QED) describes the interaction of charged particles with electromagnetic fields and is the most precisely tested physical theory. It...

Im Focus: Experimental physicists redefine ultrafast, coherent magnetism

For the first time ever, experimental physicists have been able to influence the magnetic moment of materials in sync with their electronic properties. The coupled optical and magnetic excitation within one femtosecond corresponds to an acceleration by a factor of 200 and is the fastest magnetic phenomenon that has ever been observed.

Electronic properties of materials can be directly influenced via light absorption in under a femtosecond (10-15 seconds), which is regarded as the limit of...

Im Focus: Fraunhofer IDMT demonstrates its method for acoustic quality inspection at »Sensor+Test 2019« in Nürnberg

From June 25th to 27th 2019, the Fraunhofer Institute for Digital Media Technology IDMT in Ilmenau (Germany) will be presenting a new solution for acoustic quality inspection allowing contact-free, non-destructive testing of manufactured parts and components. The method which has reached Technology Readiness Level 6 already, is currently being successfully tested in practical use together with a number of industrial partners.

Reducing machine downtime, manufacturing defects, and excessive scrap

Im Focus: Successfully Tested in Praxis: Bidirectional Sensor Technology Optimizes Laser Material Deposition

The quality of additively manufactured components depends not only on the manufacturing process, but also on the inline process control. The process control ensures a reliable coating process because it detects deviations from the target geometry immediately. At LASER World of PHOTONICS 2019, the Fraunhofer Institute for Laser Technology ILT will be demonstrating how well bi-directional sensor technology can already be used for Laser Material Deposition (LMD) in combination with commercial optics at booth A2.431.

Fraunhofer ILT has been developing optical sensor technology specifically for production measurement technology for around 10 years. In particular, its »bd-1«...

Im Focus: The hidden structure of the periodic system

The well-known representation of chemical elements is just one example of how objects can be arranged and classified

The periodic table of elements that most chemistry books depict is only one special case. This tabular overview of the chemical elements, which goes back to...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

2nd International Conference on UV LED Technologies & Applications – ICULTA 2020 | Call for Abstracts

24.06.2019 | Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

Latest News

Scientists alarmed by bark beetle boom

01.07.2019 | Agricultural and Forestry Science

Pharmaconutrition‒Modern drug design for functional studies

01.07.2019 | Life Sciences

Researchers teleport information within a diamond

28.06.2019 | Materials Sciences

Science & Research
Overview of more VideoLinks >>>